Development and characterization of a long-acting nanoformulated abacavir prodrug

AIM: A myristoylated abacavir (ABC) prodrug was synthesized to extend drug half-life and bioavailability. METHODS: Myristoylated ABC (MABC) was made by esterifying myristic acid to the drug's 5-hydroxy-cyclopentene group. Chemical composition, antiretroviral activity, cell uptake and retention...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Nanomedicine (Lond)
Autori principali: Singh, Dhirender, McMillan, JoEllyn, Hilaire, James, Gautam, Nagsen, Palandri, Diana, Alnouti, Yazen, Gendelman, Howard E, Edagwa, Benson
Natura: Artigo
Lingua:Inglês
Pubblicazione: Future Medicine Ltd 2016
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4996153/
https://ncbi.nlm.nih.gov/pubmed/27456759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/nnm-2016-0164
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi